Some cancer patients forgo lifesaving medications because of high cost
PIK Professor Ezekiel Emanuel comments on the problem with the Food and Drug Administration’s accelerated approval program for new cancer drugs.
・ From Today.com
PIK Professor Ezekiel Emanuel comments on the problem with the Food and Drug Administration’s accelerated approval program for new cancer drugs.
・ From Today.com